CAMBRIDGE, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that the company will participate in the upcoming Cowen 41st Annual Health Care Conference.

Read this article:
Cerevel Therapeutics to Present at the Cowen 41st Annual Health Care Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh